✦ LIBER ✦

Patients with Fabry disease on dialysis in the United States

✍ Scribed by Thadhani, Ravi; Wolf, Myles; West, Michael L.; Tonelli, Marcello; Ruthazer, Robin; Pastores, Gregory M.; Obrador, Gregorio T.

Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 242 KB
Volume: 61
Category: Article
ISSN: 0085-2538
DOI: 10.1046/j.1523-1755.2002.00097.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of dialysis modality on survival

Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States

✍ Stack, Austin G.; Molony, Donald A.; Rahman, Noor S.; Dosekun, Akinsansoye; Murt 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 153 KB

## Background: It is hypothesized, but not proven, that peritoneal dialysis might be the optimal treatment for end-stage renal disease (esrd) patients with established congestive heart failure (chf) through better volume regulation compared with hemodialysis. ## Methods: National incidence data o

Body size and outcomes on peritoneal dia

Body size and outcomes on peritoneal dialysis in the United States

✍ Snyder, Jon J.; Foley, Robert N.; Gilbertson, David T.; Vonesh, Edward F.; Colli 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 330 KB

Autoimmune disease concomitance among in

Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002

✍ Russell Cohen; Don Robinson Jr.; Clark Paramore; Kathy Fraeman; Kevin Renahan; M 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB 👁 1 views

## Background: Recent studies suggest that inflammatory bowel disease (ibd) may share an underlying pathogenesis with other autoimmune diseases. ## Methods: Two united states data sets with patient-level medical and drug claims were used to explore the occurrence of autoimmune diseases in patient

NAFLD may be a common underlying liver d

NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States

✍ Jorge A. Marrero; Robert J. Fontana; Grace L. Su; Hari S. Conjeevaram; Dawn M. E 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

The incidence of hepatocellular carcinoma (HCC) in the United States is increasing, but the clinical characteristics of American patients with HCC have not been well described. The aims of this study were to determine the etiology of liver disease and short-term outcome among HCC patients presenting

Thirty-four novel mutations of the GLA g

Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease

✍ Ellen Schäfer; Karin Baron; Urs Widmer; Patrick Deegan; Hartmut P.H. Neumann; Ge 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

Fabry disease (FD) is an X-chromosomal disorder caused by mutations in the GLA gene encoding the lysosomal enzyme α-galactosidase A. We performed mutation screening on a cohort of 121 patients including 84 male and 37 female index cases and identified a total of 90 different mutations, 34 of which a

Excellent posttransplant survival for pa

Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States

✍ Anita Afzali; Kristin Berry; George N. Ioannou 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Because of the ongoing epidemics of obesity and diabetes, nonalcoholic steatohepatitis (NASH) may become a leading indication for liver transplantation. There are concerns about the posttransplant survival of patients with NASH because of associated cardiovascular and metabolic risk factors. We aime